Hoʻokumu ʻia ma 2009, ʻo JYMed kahi mea lawelawe peptide CRDMO alakaʻi a me ka mea hana API maʻamau ma Kina e ʻike nui ana i ka synthesis maʻamau, ka hoʻomohala ʻana i ke kaʻina hana, ka lako lapaʻau a me ka hoʻolaha ʻana o nā mea peptide. Hoʻohana ka hui ma kahi o 600+ FTE, me kahi hui hoʻokele koʻikoʻi i haku ʻia e nā poʻe loea me nā makahiki he 20 o ka ʻike i ka ʻenehana peptide. Hoʻohana ʻo JYMed i hoʻokahi kikowaena R&D a me ʻelua mau keʻena hana multi-purpose nui, me ka mana hana peptide scale multi-ton.

E pili ana
JYMED

ʻO JYMed kahi mea hana peptide i nānā ʻia e ka US FDA e loea i nā peptides cosmetic, API peptide, a me nā peptides maʻamau. ʻO kā mākou huahana i hōʻike ʻia ʻo Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, a me nā mea hou aku. No ka ʻike hou aku, e ʻoluʻolu e kelepona mai iā mākou ma:

Email: jymed@jymedtech.com

nūhou a me ka ʻike

,